All you do is conjure stuff in your head and run with it. You're NOT posting to ignorant people. Even BP applications to the FDA sometimes are returned for all sorts of reasons, how much more an OTC startup?
At least Korenko advanced a product to the FDA for review. I know several companies on the major exchanges with decades long presence in the market with zero history of advancing anything in their pipeline beyond pre-clinial stage. You need to slow sown on your hypocritical passive aggressive jabs against Vivos. You have a penchant for overreacting and salivating at any opportunity to see the sp fall. If you don't like Korenko's management style that you feel adversely affects your investment in RDGL, perhaps you consider exiting your stake and moving on?
Market Data 
Markets 
AI
